Differential pharmacokinetics of lithium in elderly patients.
about
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder.Brain lithium levels and effects on cognition and mood in geriatric bipolar disorder: a lithium-7 magnetic resonance spectroscopy studyBrain lithium, N-acetyl aspartate and myo-inositol levels in older adults with bipolar disorder treated with lithium: a lithium-7 and proton magnetic resonance spectroscopy study.Lithium use in special populationsWorld Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care.Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for PsychopharmacologyEvidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology.Antihypertensive therapy: special focus on drug interactions.Aging and clinical pharmacology: implications for antidepressants.Lithium in late-life mania: a systematic review.Hyponatremia and heart failure--treatment considerations.Pharmacokinetics and interactions of headache medications, part II: prophylactic treatments.Discontinuation of lithium augmentation in geriatric patients with unipolar depression: a systematic review.Lithium treatments: single and multiple daily dosing.Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology.Pharmacokinetics and drug metabolism in the elderly.Current electroconvulsive therapy practice and research in the geriatric populationOptimal frequency of lithium administration in the treatment of bipolar disorder: clinical and dosing considerations.Use of lithium in the treatment of bipolar disorder in late-life.The science and practice of lithium therapy.Lithium dosing and serum concentrations across the age spectrum: from early adulthood to the tenth decade of life.Glycogen synthase kinase-3 as a therapeutic target for cognitive dysfunction in neuropsychiatric disorders.Chronic kidney disease in lithium-treated older adults: a review of epidemiology, mechanisms, and implications for the treatment of late-life mood disorders.Population Pharmacokinetic Analyses of Lithium: A Systematic Review.Is environmental temperature related to renal symptoms, serum lithium levels, and other laboratory test results in current lithium users?Lithium intoxication as a result of an interaction with rofecoxib.The lithiumeter: a measured approach.The effect of serum lithium levels on renal function in geriatric outpatients: a retrospective longitudinal study.Lithium Intoxication: A Possible Interaction with Moxifloxacin.Clinically relevant treatment considerations regarding lithium use in bipolar disorder.Lithium poisoning in the intensive care unit: predictive factors of severity and indications for extracorporeal toxin removal to improve outcome.Association between glomerular filtration rate and adverse drug reactions in elderly hospitalized patients: the role of the estimating equation.
P2860
Q31121208-1515D871-5485-473F-83B1-96B73CBB8847Q33859418-B65F3624-33E4-4C55-9C6B-420FBC657711Q33908187-607E979A-EFE8-4191-8413-863E39292346Q33985019-BB231FD3-01ED-472C-BF64-61A21CEBEC5DQ34578945-A2AD7800-4D58-4FD2-88C5-908CCC62E99BQ34676317-12154F75-1344-4109-9389-4251CB0D82AAQ35180787-1B16CEA7-2DB8-422B-82DF-5212ADC94E83Q35570981-3380060E-4953-4F73-8D5F-FED5290C2EEFQ36261418-5719BEF9-36A9-4DB8-9A32-D060FB6AA4F3Q36319067-BECCB995-DA9A-4573-B4DC-C02A554097F3Q36392706-231817A6-78E5-4635-B43C-836C0FA2968CQ36662893-FE3CF718-5A01-466A-80FB-11EAD0032399Q37115700-DCC6A17A-F549-42FC-953B-61FC62BBC6B5Q37190650-DB34FFE7-AF89-4406-ADBB-8C785AC91501Q37426143-0F96A527-09F0-4E33-B629-EF75CA1B1BDEQ37514319-A08EB55B-DD2A-49F9-9DC0-BCE96A293290Q37723970-A9E57977-E459-4659-9F4B-AE3CFC43EFC1Q37855777-16F19C2F-050C-402A-AF81-3CEE9D22FE13Q37918851-04E367FF-50F3-4E9E-A2D0-9C98AD1D91E6Q37990676-CC4E636E-92C4-4C5F-B67A-917F19A68B7DQ38261597-CE01B91B-3BA7-4484-8B3D-A3A6A6EE7BCBQ38266162-8B18BF61-9AE0-45D9-9C18-16566C52779FQ38292314-A63AF4AC-2079-4211-9866-A0B12EEB6C90Q38677570-CF56FE60-328A-4990-883C-2F879B9BCBA2Q39138853-53B2CBEE-75D0-4081-B900-A7C969D46A54Q44929052-3F3EBC2C-03A2-465F-B141-1D7F94E39611Q45862905-BCC2E7E6-CD2C-4927-9C83-CAA431FA21F9Q45908763-59352ABF-C363-429F-9FC5-DA33E6D62B61Q47138846-EDA644B8-C823-47B9-9A69-A687A9CF8848Q47753611-DF4AC0CB-51A0-4302-8961-94AAEBC6C346Q47781046-42B87155-4168-4E93-81EF-03473BC2CBE6Q51572266-7B0F1629-B2D4-4EB9-877E-C4BA17EECA54
P2860
Differential pharmacokinetics of lithium in elderly patients.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Differential pharmacokinetics of lithium in elderly patients.
@ast
Differential pharmacokinetics of lithium in elderly patients.
@en
type
label
Differential pharmacokinetics of lithium in elderly patients.
@ast
Differential pharmacokinetics of lithium in elderly patients.
@en
prefLabel
Differential pharmacokinetics of lithium in elderly patients.
@ast
Differential pharmacokinetics of lithium in elderly patients.
@en
P2093
P2860
P1433
P1476
Differential pharmacokinetics of lithium in elderly patients.
@en
P2093
P2860
P304
P356
10.2165/00002512-200016030-00002
P577
2000-03-01T00:00:00Z
P6179
1021445234